|
Article Title |
Issue |
| Regional Report Triad_April 2010 | 2010-04 |
Mac Williams admits it grudgingly — after being prodded a few times.
Yes, the president of the Alamance County Area Chamber of Commerce
concedes, it hurt when Burlington-based Laboratory Corporation of
America Holdings decided to put a billing center in Greensboro. |
|
| |
| Regional Report Triangle December 09 | 2009-12 |
Until Talecris Biotherapeutics Holdings Corp. broke the ice in October,
no Triangle company had gone public in more than two years. |
|
| |
| Regional Report Triad December 09 | 2009-12 |
Fall has been a season of rising fortunes for Targacept Inc. In
October, the Winston-Salem-based drug developer netted $44.4 million in
less than 24 hours by selling 2.2 million shares of stock. |
|
| |
| David Green | 2008-12 |
| David Green moved to Durham from his native Pittsburgh when he was 12.
He graduated from Davidson College in 1976 with a bachelor’s in biology
and earned a master’s from East Carolina University in 1980 and a Ph.D.
from N.C. State six years later.
|
|
| |
| Bob Peele | 2008-12 |
| For 10 years, Bob Peele, 45, has overseen operations at Wanchese Seafood Industrial Park, a 60-acre site that opened in 1981.
|
|
| |
| Oliver Smithies | 2008-06 |
| The call came early in the morning — 4:45, to be exact — but for Oliver
Smithies, it wasn’t a minute too soon. For years, colleagues had told
the UNC professor he was up for the Nobel Prize in medicine for his
ground-breaking research in genetics, but as the years went by with no
word from Sweden, he learned to ignore the rumors. When the call
finally came last October, it was “a feeling of relief as much as
anything else. A feeling of, well, that’s good. That’s finished.”
|
|
| |
| Stan Eskridge | 2008-06 |
| When Stan Eskridge wanted to help Tom Fischer make an inexpensive
bandage that quickly stops bleeding, he turned to his connections. “You
can’t be a North Carolina native and not know somebody in the textile
industry,” Eskridge, 65, says. His friends helped find the materials to
develop Stasilon, a bandage woven from bamboo yarn and glass filament,
approved for use by the U.S. Food and Drug Administration in September.
|
|
| |
| Martin Posey | 2008-06 |
| Martin Posey, chairman of the Department of Biology and Marine Biology
at UNC Wilmington, is among a handful of scientists working to restore
the Tar Heel oyster population, estimated to be 5% to 10% of what it
was in the early 1900s.
|
|
| |
| Frank Torti | 2008-06 |
| In May, Torti, 60, departed Winston-Salem and his job as director of
the Comprehensive Cancer Center at Wake Forest University Baptist
Medical Center for the Washington, D.C., suburbs to take up a new
position at the FDA. An experienced clinical researcher specializing in
urologic oncology, he will oversee research efforts and launch a
fellowship program created, like his job, by the FDA Amendments Act of
2007.
|
|
| |
| Tipping point - Life Sciences | 2008-02 |
Charles Hamner retired in 2002 after 14 years as the CEO of
the nonprofit North Carolina Biotechnology Center in Research Triangle
Park. A biochemist and veterinarian, he helped the state’s biotech
industry grow into one of the nation’s top five, nearly tripling the
number of companies. During his tenure, the center invested more than
$50 million in the state’s universities, provided seed money to 62
startups and helped recruit more than a dozen companies.
|
|
| |
| Christy Shaffer | 2007-12 |
| Christy Shaffer can thank the board for knowing her better than she
knew herself. With products on the market and a rich pipeline, Inspire
Pharmaceuticals is one of the few true successes of the Triangle
biotech scene. But without the board’s trickery, she never would’ve
become its boss.
|
|
| |
| Kay Wagoner | 2007-12 |
| In the 14 years since starting Icagen, Kay Wagoner, 58, has seen more ups and downs than Keith Richards’ blood-alcohol level.
|
|
| |
| Maybe it will make new code medicines | 2007-06 |
| What does writing code have to do with the genetic code? Maybe nothing,
but that’s not the reason Red Hat Inc. is opening an office at the
state’s newest biotechnology hot spot.
|
|
| |
| Profit doesn't heal this drug developer | 2007-05 |
| The day Trimeris Inc. announced it was profitable should have been a
happy one. But two other announcements that same day left analysts
wondering whether the 14-year-old Morrisville drug developer has much
of a future.
|
|
| |
| The Wonderer | 2007-04 |
Pilot Therapeutics’ odyssey leads a scientist to discover there’s more — and less — to business than he thought.
|
|
| |
| Investments inject new life into sector | 2007-02 |
When Intersouth Partners sought investors early last year, the Durham venture-capital firm didn't have to look hard. Intersouth closed its fund in May with $275 million, the most it has ever raised. "Venture fundraising has been on a tear," spokeswoman Suzanne Cantando says.
|
|
| |
| Holly Springs gets stuck by incentives | 2006-10 |
Maybe Holly Springs should hold a really big bake sale. But the town would have to sell a lot of cookies, brownies and cakes to make up the $11.8 million gap between what it has promised to spend on Swiss drug maker Novartis to land a vaccine plant and what it has on hand.
|
|
| |
| Heavy industry | 2006-07 |
There’s no dearth of girth. But rather than expand, Durham’s Rice Diet and its brethren watch their wait.
|
|
| |
| Luck of the draw | 2006-03 |
Charles Sanders knows a doc can't always pick his patients.
|
|
| |
| Biotech develops formula that nurtures job growth | 2006-02 |
Several times a week during much of the last year, Monica Doss answered her phone to find someone from the West Coast calling to ask about the state’s life-sciences industry. Most were California biotech veterans. About half told her they planned to move to North Carolina — whether a job was waiting or not.
|
|
| |
| The Atkins Diet has business cooking | 2006-01 |
John Troy’s experience with the Atkins Diet mirrored that of many Americans. He got spectacular short-term gains but couldn’t maintain them.
|
|
| |
| Grow your own | 2005-07 |
| Tony Atala is on the hot seat, though he’s fielding easy questions. He
struggles to recall he’s 46, was born in South America and grew up
mostly in Boca Raton, Fla. Asked when he got his bachelor’s from the
University of Miami, he tilts his eyes toward a spot near where the
ceiling meets a wall. “I got a bachelor’s there in, uh, uh — I forget
the year, but it’s on my CV.”
|
|
| |
| Money proves to be real pill for industry | 2005-02 |
| Executives at life-sciences companies in North Carolina have at least one thing to be thankful for: Their industry’s popularity with venture capitalists isn’t fading as fast as it has for some others. Through three quarters of 2004, they had grabbed 29% of the venture capital received by North Carolina companies, compared with 14.4% during the first nine months of 2000.
|
|
| |
| 2005 tar heel industry reports | 2005-02 |
|
|
| |
| Firm returns from the grave a profit | 2005-01 |
Imagine Perry Mason confronting a wife who has bumped off her husband for the insurance money. “He was worth more to you dead than alive, wasn’t he?” Durham’s Volumetrics Medical Imaging Inc. is like that. It was buried in February 2001, but thanks to a lawsuit, it’s worth more than ever.
|
|
| |
